Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides
Open Access
- 1 September 2009
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 37 (2) , 226-234
Abstract
Purpose In peptide-receptor radionuclide therapy (PRRT), the maximum activity dose that can safely be administered is limited by high renal uptake and retention of radiolabelled peptides. The kidney radiation dose can be reduced by coinfusion of agents that competitively inhibit the reabsorption of radiolabelled peptides, such as positively charged amino acids, Gelofusine, or trypsinised albumin. The aim of this study was to identify more specific and potent inhibitors of the kidney reabsorption of radiolabelled peptides, based on albumin. Methods Albumin was fragmented using cyanogen bromide and six albumin-derived peptides with different numbers of electric charges were selected and synthesised. The effect of albumin fragments (FRALB-C) and selected albumin-derived peptides on the internalisation of 111In-albumin, 111In-minigastrin, 111In-exendin and 111In-octreotide by megalin-expressing cells was assessed. In rats, the effect of Gelofusine and albumin-derived peptides on the renal uptake and biodistribution of 111In-minigastrin, 111In-exendin and 111In-octreotide was determined. Results FRALB-C significantly reduced the uptake of all radiolabelled peptides in vitro. The albumin-derived peptides showed different potencies in reducing the uptake of 111In-albumin, 111In-exendin and 111In-minigastrin in vitro. The most efficient albumin-derived peptide (peptide #6), was selected for in vivo testing. In rats, 5 mg of peptide #6 very efficiently inhibited the renal uptake of 111In-minigastrin, by 88%. Uptake of 111In-exendin and 111In-octreotide was reduced by 26 and 33%, respectively. Conclusions The albumin-derived peptide #6 efficiently inhibited the renal reabsorption of 111In-minigastrin, 111In-exendin and 111In-octreotide and is a promising candidate for kidney protection in PRRT.Keywords
This publication has 38 references indexed in Scilit:
- MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response—Implications for Radionuclide TherapyJournal of Nuclear Medicine, 2008
- Reducing Renal Uptake of Radiolabeled Peptides Using Albumin FragmentsJournal of Nuclear Medicine, 2008
- Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factorsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2008
- Molecular imaging of reduced renal uptake of radiolabelled [DOTA0,Tyr3]octreotate by the combination of lysine and Gelofusine in ratsNuklearmedizin-Nuclear Medicine, 2008
- Characterization of proteinuria and tubular protein uptake in a new model of oral L-lysine administration in ratsKidney International, 2006
- Renal albumin absorption in physiology and pathologyKidney International, 2006
- RENAL TUBULE ALBUMIN TRANSPORTAnnual Review of Physiology, 2005
- Megalin and cubilin, role in proximal tubule function and during developmentPediatric Nephrology, 2002
- Messenger rna expression of somatostatin receptor subtypes in human and rat gastric mucosaeLife Sciences, 1996
- Studies on renal tubular protein reabsorption: Partial and near complete inhibition by certain amino acidsScandinavian Journal of Clinical and Laboratory Investigation, 1977